Cyclic Glycine-Proline

FDA APPROVAL PENDING

Experimental

Cognitive

Longevity

Cyclic Glycine-Proline

IGF-1 Modulator | Neuroprotection & Cognitive Health

Learn more

Cognitive

Cyclic Glycine-Proline

Longevity

0

Amino acids

154.17da

Molecular weight

Peptide

Type

Cyclic Glycine-Proline (cGP) is an endogenous cyclic dipeptide and 2,5-diketopiperazine metabolite derived from the N-terminal of insulin-like growth factor-1 (IGF-1). It regulates IGF-1 bioavailability by competitively binding to IGF-binding protein-3 (IGFBP-3), normalizing IGF-1 activity in a bidirectional, homeostatic manner. Research is predominantly in animal models and observational human studies, with exploratory clinical work examining its role in aging, stroke, Alzheimer's disease, and metabolic disorders.

Top researched benefits

Overview of Cyclic Glycine-Proline

cGP competes with IGF-1 for binding to IGFBP-3, altering the ratio of bound to free IGF-1 in circulation and cerebrospinal fluid. This bidirectional regulation normalizes IGF-1 bioactivity — increasing free IGF-1 when levels are insufficient and dampening excess — while downstream effects include promotion of vascular remodeling, neurogenesis, and synaptic plasticity via IGF-1 receptor pathways.

neurological

  • Higher cGP levels correlate with improved memory retention in elderly populations
  • Protects neural stem cells from oxidative stress; efficacy demonstrated in stroke models
  • Mouse studies show reduced amyloid plaque load and improved spatial memory
  • Clinical study showed increased CSF cGP and reduced anxiety/depression scores

metabolic

  • Clinical trial improved vascular complications and normalized HbA1c%
  • Demonstrated systolic blood pressure reduction in clinical observations

recovery

  • Higher cGP/IGF-1 ratios associated with favorable clinical outcomes
  • Maintained ratios correlate with preserved cognitive function with age

Typical Dose

20-100 μg daily (or 300mg blackcurrant extract 2x daily)

Frequency

Once daily, preferably in the morning

Cycle Duration

4-12 weeks

Storage

Powder: store at -20°C in a dry, desiccated environment. Soluble in DMSO (5–10 mg/mL). No established clinical reconstitution protocol; general research practice is refrigeration at 2–8°C after dissolution.

No visual available

Due to this peptide having no amino acids, there is no molecular chain to display.

Chemical Makeup

Key benefits

Normalizes bioavailable IGF-1 by competitively displacing it from IGFBP-3, restoring declining IGF-1 activity in aging and neurodegenerative conditions

Reduces amyloid plaque burden and improves spatial memory in Alzheimer's disease mouse models (APP/PS1 transgenic)

Higher plasma cGP/IGF-1 molar ratios correlate with more favorable functional outcomes in stroke patients across observational studies

Exerts neuroprotective effects against ischemic brain injury by inhibiting apoptosis, reducing neuroinflammation, and supporting neurogenesis in rodent models

Community interest

This peptide is still gaining traction in the community.

IGF-1 Modulator | Neuroprotection & Cognitive Health

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Cyclic Glycine-Proline Molecular Information

View the scientifc details of Cyclic Glycine-Proline.

Molecular Weight

154.17Da

Chain Length

0Amino Acids

Type

Peptide

Cyclic Glycine-Proline Protocols

Oral administration is the primary human-use route for Cyclic Glycine-Proline, supported by clinical trial data and confirmed CNS penetration following oral intake. Traneurocin (NA-831) has been tested at 10–30 mg/day in Alzheimer's disease trials; natural food-derived supplements deliver approximately 40 mcg of cGP per 100 mg of extract.

GoalDosageFrequencyRoute
Improve cognitive function in mild cognitive impairment (MCI) using the lowest effective synthetic cGP dose101 day rangeOral
Slow cognitive decline and support neuroprotection in mild-to-moderate Alzheimer's disease301 day rangeOral
Prevent cognitive decline in asymptomatic high-risk individuals by restoring IGF-1 bioavailability101 day rangeOral
Support IGF-1 homeostasis and general neuroprotection using a physiological dose of natural cGP from blackcurrant extract0.041 day rangeOral — 40 mcg as natural cGP extract (e.g. 100 mg cGP-PRo providing ≥40 mcg cGP)
Facilitate cognitive rehabilitation and task-learning recovery following ischemic stroke1 day rangeOral
Reduce vascular complications and support IGF-1 regulation in type-2 diabetes patients1 day rangeOral (natural cGP supplementation)

Cyclic Glycine-Proline Cycle

The Cyclic Glycine-Proline Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2
Possible subtle improvements in mental clarity
Week 2-4
Enhanced cognitive function and focus may become noticeable
Week 4-8
Neuroprotective and metabolic benefits accumulating
Week 8-12
Optimal IGF-1 regulation and sustained cognitive support

Dosing tools

Cyclic Glycine-Proline Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

Cyclic Glycine-Proline

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Cyclic Glycine-Proline vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
Cyclic Glycine-Proline
Dosing
20-100 μg daily (or 300mg blackcurrant extract 2x daily)
Dosing Frequency
Once daily, preferably in the morning
Cycle Duration
4-12 weeks
Storage
Powder: store at -20°C in a dry, desiccated environment. Soluble in DMSO (5–10 mg/mL). No established clinical reconstitution protocol; general research practice is refrigeration at 2–8°C after dissolution.

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Cyclic Glycine-Proline interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

Different pathways; BPC-157 promotes tissue repair, cGP modulates IGF-1

COMPATIBLE

Cognitive

sel

Longevity

Selank

COMPATIBLE

Complementary cognitive effects; Selank addresses anxiety, cGP optimizes IGF-1

COMPATIBLE

Cognitive

sema

Longevity

Semax

COMPATIBLE

Both offer neuroprotection and nootropic effects through distinct pathways

COMPATIBLE

Side effects

Contraindications

Consult healthcare provider if taking IGF-1 or growth hormone medications

Limited long-term human data available

Not studied in pregnancy

Stop signs

Allergic reactions (rash, difficulty breathing, swelling)

Unexpected blood glucose changes

Unusual fatigue or weakness

Bad signs

Extreme therapeutic claims unsupported by researchVague concentration descriptions
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

Cyclic Glycine-ProlineResearch References

Cyclic Glycine-Proline is an experimental compound

4Research references

Cyclic Glycine-Proline

Cyclic Glycine-Proline is an experimental compound

IGF-1 Homeostasis Regulation Study

cGP regulates IGF-1 bioavailability through IGFBP-3 competitive binding

n.d.

Alzheimer's Mouse Model Study

Significantly improved spatial memory; reduced hippocampal plaques 42.3→14.5 per mm²

n.d.

Parkinson's Disease Clinical Study

Blackcurrant supplementation increased CSF cGP 74%; reduced anxiety/depression

n.d.

Stroke Recovery & Cognitive Function Review

Higher cGP/IGF-1 ratios associated with favorable stroke outcomes

n.d.

Calculate peptide dosages

Learning how to calculate a peptide dose? Use our beginner-friendly peptide dosage, blend, and accumulation calculators. Enter vial size, reconstitution volume, and target dose to get exact draw volumes instantly. No guesswork, just clear guidance that helps prevent common mistakes.